Login / Signup

Weighing the risks and benefits of PJP prophylaxis in rituximab users.

Zachary Scott WallaceMichael Putman
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • human health
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • risk assessment